NCT02522377View on ClinicalTrials.gov

Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

March 1, 2018

Study Completion Date

March 1, 2018

Conditions
Treatment Resistant DepressionMajor Depressive DisorderSevere Depression
Interventions
DRUG

Ketamine

inter venous injections

DRUG

Midazolam

inter venous injections

Trial Locations (1)

44195

Cleveland Clinic Foundation Center for Behavioral Health, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT02522377 - Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression | Biotech Hunter | Biotech Hunter